Cargando…

Management of Low-Risk Papillary Thyroid Cancer

The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Iñiguez-Ariza, Nicole M., Brito, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021317/
https://www.ncbi.nlm.nih.gov/pubmed/29947175
http://dx.doi.org/10.3803/EnM.2018.33.2.185
_version_ 1783335443491717120
author Iñiguez-Ariza, Nicole M.
Brito, Juan P.
author_facet Iñiguez-Ariza, Nicole M.
Brito, Juan P.
author_sort Iñiguez-Ariza, Nicole M.
collection PubMed
description The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.
format Online
Article
Text
id pubmed-6021317
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-60213172018-06-29 Management of Low-Risk Papillary Thyroid Cancer Iñiguez-Ariza, Nicole M. Brito, Juan P. Endocrinol Metab (Seoul) Review Article The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC. Korean Endocrine Society 2018-06 2018-06-21 /pmc/articles/PMC6021317/ /pubmed/29947175 http://dx.doi.org/10.3803/EnM.2018.33.2.185 Text en Copyright © 2018 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Iñiguez-Ariza, Nicole M.
Brito, Juan P.
Management of Low-Risk Papillary Thyroid Cancer
title Management of Low-Risk Papillary Thyroid Cancer
title_full Management of Low-Risk Papillary Thyroid Cancer
title_fullStr Management of Low-Risk Papillary Thyroid Cancer
title_full_unstemmed Management of Low-Risk Papillary Thyroid Cancer
title_short Management of Low-Risk Papillary Thyroid Cancer
title_sort management of low-risk papillary thyroid cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021317/
https://www.ncbi.nlm.nih.gov/pubmed/29947175
http://dx.doi.org/10.3803/EnM.2018.33.2.185
work_keys_str_mv AT iniguezarizanicolem managementoflowriskpapillarythyroidcancer
AT britojuanp managementoflowriskpapillarythyroidcancer